Our Magazine
Brussels Morning Online Newspaper
Thursday, April 15, 2021
No Result
View All Result
  • Home
    • About Us
  • EU institutions
    • Commission
    • Parliament
    • Council
  • Europe
  • World
  • Economy
  • Culture and Society
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Europe With Transparency
    • Sustainable Perspective
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
Brussels Morning Online Newspaper
  • Home
    • About Us
  • EU institutions
    • Commission
    • Parliament
    • Council
  • Europe
  • World
  • Economy
  • Culture and Society
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Europe With Transparency
    • Sustainable Perspective
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
Brussels Morning Online Newspaper
No Result
View All Result
Home World Diplomacy

Australia calls on EU to release 3.1 million vaccine doses

Nikola Kiš by Nikola Kiš
7 April 2021
in Diplomacy
Australia calls on EU to release 3.1 million vaccine doses
Share on FacebookShare on Twitter

Brussels (Brussels Morning) Australia has called on the EU to release 3.1 million doses of COVID-19 vaccine developed by British-Swedish AstraZeneca, Reuters reported on Wednesday.

Prime Minister Scott Morrison said “we obviously want those millions of doses”, adding that the shots had been scheduled to arrive in Australia by the end of the first quarter this year.

Morrison said the EU had called on Australia to withdraw its export permit applications and that the bloc had not answered official requests for supplies.

EU claims it did not block shipments

On Tuesday, the EU denied it was blocking shipments to Australia and said that AstraZeneca’s failure to deliver to other countries could not be blamed on the bloc.

“Given statements made overnight, that apparently there is no obstruction”, Morrison indicated he hoped the issue “could be readily addressed”. He stressed that he was not criticising the EU.

Australia’s Federal Treasurer, Josh Frydenberg, in an interview with ABC Radio, maintained that “not giving approval is effectively the same as blocking“.

The Australian government claims the delayed shipment of 3.1 million doses is to blame for the nation’s slow vaccine rollout. The plan was to vaccinate 4 million citizens by the end of March, yet only some 670,000 were actually inoculated.

Australia has seen comparatively few coronavirus infections compared to most countries and the number of daily new confirmed cases has remained below 50 since the end of September last year.

According to Australian officials, the country received 300,000 doses of the vaccine developed by AstraZeneca in February.

One shipment was blocked 

Italy blocked a shipment of AstraZeneca vaccines to Australia last month at the request of the European Commission, which cited shortages in the bloc at the time.

Australia was counting on AstraZeneca vaccines from the EU for the early stages of its vaccination campaign, to supplement some 50 million doses made locally.

Besides the AstraZeneca vaccine, Australia imported vaccines developed by US Pfizer pharmaceuticals, which were used for inoculating healthcare workers.

Subscribe to Our Newsletter

Nikola Kiš

Nikola Kiš

Nikola is Brussels Morning political affairs reporter, covering Germany, France, and Italy. Based in Zagreb, he is a translator with 18 years of experience reporting on political and business affairs.

Latest post

Now the Digital Markets Act is here, could this be what tames big tech?

Now the Digital Markets Act is here, could this be what tames big tech?

12 hours ago
Pandemic‌ ‌to‌ ‌set‌ ‌French‌ ‌finances‌ ‌back‌ ‌€424bn‌ ‌over‌ ‌three‌ ‌years‌ ‌

Pandemic‌ ‌to‌ ‌set‌ ‌French‌ ‌finances‌ ‌back‌ ‌€424bn‌ ‌over‌ ‌three‌ ‌years‌ ‌

17 hours ago

Most Read

  • A very Georgian provokatsiya

    A very Georgian provokatsiya

    0 shares
    Share 0 Tweet 0
  • The EU’s newest member state Croatia can teach the bloc much about building strategic autonomy

    0 shares
    Share 0 Tweet 0
  • EC to investigate €1bn worth of missing lumber in Croatian forests

    0 shares
    Share 0 Tweet 0
  • Salmond’s strategic masterstroke

    0 shares
    Share 0 Tweet 0
  • Vaccine export bans won’t help the fight against Covid-19, says Pfizer

    0 shares
    Share 0 Tweet 0

Subscribe
Facebook Twitter Youtube LinkedIn

About Us

Brussels Morning is a daily online newspaper based in Belgium. BM publishes unique and independent coverage on international and European affairs. With a Europe-wide perspective, BM covers policies and politics of the EU, significant Member State developments, and looks at the international agenda with a European perspective.

Category

  • Ambassador’s Corner
  • Commission
  • Council
  • Culture and Society
  • Diplomacy
  • Economy
  • EU Institutions
  • Europe
  • Europe With Transparency
  • Features
  • In Depth
  • Member States
  • Middle East Eye
  • Opinion
  • Our pick
  • Parliament
  • Place de la Bourse
  • Southeast Europe
  • Sustainable Perspective
  • The American Angle
  • The Macro-Economist
  • Uncategorised
  • US Elections
  • World

More info

  • About Us
  • Advertising
  • Cookies Policy
  • Contact Us
  • FAQ
  • Jobs

Brussels Morning Newspaper - All Rights Reserved © 2020

No Result
View All Result
  • Home
  • About Us
  • EU Institutions
    • Parliament
    • Commission
    • Council
  • Europe
  • World
  • Member States
  • Economy
  • Culture and Society
  • In Depth
    • Ambassador’s Corner
    • Europe With Transparency
    • Place de la Bourse
    • The Macro-Economist
    • Sustainable Perspective
    • The American Angle
    • Southeast Europe
  • Magazine

Brussels Morning Newspaper - All Rights Reserved © 2020

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT